Semaglutide is effective in type 2 diabetes and obesity with schizophrenia
Kaoru Noda, Takehiro Kato, Nao Nomura, Mayu Sakai, Sodai Kubota, Tokuyuki Hirose, Yanyan Liu, Yoshihiro Takahashi, Ken Takao, Masami Mizuno, Takuo Hirota, Tetsuya Suwa, Yukio Horikawa, Daisuke Yabe
Topics & Concepts
SemaglutideMedicineType 2 diabetesObesityDiabetes mellitusSchizophrenia (object-oriented programming)Internal medicinePsychiatryEndocrinologyLiraglutideDiabetes Treatment and ManagementDiabetes Management and ResearchBariatric Surgery and Outcomes